Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) has 232 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Mar, 2026 | 15,759,799 | 1,466,024 | 10.26% | $572,395,895.00 |
| FMR LLC | 31 Mar, 2026 | 14,293,775 | 106,277 | 0.75% | $665,375,245.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 9,135,504 | -34,625 | -0.38% | $425,257,712.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 9,040,502 | 4,599,811 | 103.58% | $328,454,390.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 8,478,815 | 490,267 | 6.14% | $307,950,573.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 8,338,098 | 1,405,000 | 20.27% | $302,839,719.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 8,157,204 | 119,315 | 1.48% | $296,269,650.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 8,037,889 | -344,102 | -4.11% | $374,163,733.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 7,988,548 | 401,951 | 5.30% | $371,866,926.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 6,933,098 | -4,607,098 | -39.92% | $322,735,712.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 6,395,922 | 8,182 | 0.13% | $232,299,887.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 6,387,740 | -93,873 | -1.45% | $297,349,297.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 5,355,496 | 5,355,496 | 0.00% | $194,513.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,673,935 | 4,673,935 | 0.00% | $169,757,319.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 4,638,511 | 4,638,511 | 0.00% | $168,470,720.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 4,440,691 | 581,900 | 15.08% | $206,603,847.00 |
| EcoR1 Capital, LLC | 31 Mar, 2026 | 4,288,120 | 0 | 0.00% | $155,744,518.00 |
| EcoR1 Capital, LLC | 31 Mar, 2026 | 4,288,120 | 0 | 0.00% | $199,611,986.00 |
| Bellevue Group AG | 31 Mar, 2026 | 3,280,000 | 3,275,960 | 81,088.12% | $119,129,600.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,480,763 | 238,132 | 10.62% | $90,119,429.00 |